2022 annual financial data
Kyntra Bio 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -103.69%.
Operating income was -301,025,000 USD and net income was -293,654,000 USD.
Operating cash flow was -145,933,000 USD.
Get free Kyntra Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 140,734,000 USD
- Operating income
- -301,025,000 USD
- Net income
- -293,654,000 USD
- Operating cash flow
- -145,933,000 USD